RMTI
ROCKWELL MEDICAL, INC.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$8.07
−0.25%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$7.96
From 52W high−35.95%
Volume11423.00
Market cap$32.53M
P/E (TTM)—
P/S (TTM)0.5x
Div yield—
Key dataNov 4, 2026
Open
$7.96
From 52W high
−35.95%
Volume
11423.00
Market cap
$32.53M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−11.7x
P/E (TTM)
—
RSI (14)
58.2
MomentumView details →
1D Return
−0.25%
YTD Return
−2.64%
SummaryUpdated Jun 1, 2026
Rockwell Medical, Inc. (NASDAQ:RMTI) is a biopharmaceutical company founded in 1996 and headquartered in Wixom, Michigan. The company went public in 1998 and has evolved from a diversified medical products company into a focused provider of hemodialysis concentrates and related products for kidney dialysis treatment. Over its nearly three-decade history, Rockwell has undergone significant strategic repositioning, particularly in recent years, transitioning away from drug development to concentrate on its core dialysis support business, which has become the second-largest supplier of dialysis concentrates in the United States.
Similar companies
Latest newsMore news →
Rockwell Medical entered into a loan, security and guarantee agreement for $100 million in term loans, comprising two $50 million tranches, to finance the acquisition.21h agoVANTIVE announced a definitive agreement to divest most of its hemodialysis assets and associated operations to ROCKWELL MEDICAL, INC..1d agoROCKWELL MEDICAL, INC. announced that it will release its third-quarter 2026 results on November 12, 2026.20d ago